Skip to content
MarketScale
‹ Back to IndustriesHealthcare

POWER BREEZER AND O2 OFFER RELIEF AS THE MERCURY SOARS IN SOUTH AFRICA

For much of the world, 2018 will be remembered as the “Year of the heat wave”. Temperatures have reached record highs across the globe, fueling massive wildfires and landing thousands of people in the hospital with heat stress in Asia, the Middle East, Europe, Australia, and now South Africa. Heat Waves are Becoming More Common…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

For much of the world, 2018 will be remembered as the “Year of the heat wave”. Temperatures have reached record highs across the globe, fueling massive wildfires and landing thousands of people in the hospital with heat stress in Asia, the Middle East, Europe, Australia, and now South Africa.

Heat Waves are Becoming More Common around the Globe

The World Meteorological Organization (WMO) defines a heat wave as “marked unusual hot weather over a region persisting at least two consecutive days during the hot period of the year based on local climatological conditions, with thermal conditions recorded above given thresholds.” The WMO also notes that heat waves result in the mortality of people, creates agricultural losses, and increases the occurrence of many dangers such as health-related risks, wildfires, power shortages, and accidents. Global warming is contributing to heat waves with record high temperatures on every continent and even above the Arctic Circle. Arthur Wyn, co-author of the Special Report on Global Warming issued by the Intergovernmental Panel on Climate Change (IPCC) says, “It is now the scientific consensus that global warming affects human health, causing loss of millions of lives.”

South Africa is Reaching New Record High Temperature 

Even in late October, heat waves were sweeping South Africa, bringing sweltering conditions and causing high fire danger conditions. In the capital city of Cape Town, extreme weather conditions continued for over a week, with little hope for relief. In fact, a number of temperature records for October were broken due to the scorching heat.

Breezer Mobile Cooling Can Help Provide Relief from the Heat 

Obviously, global warming and the resulting record number of heat waves is a global concern with no simple answers. However, Breezer Mobile Cooling can help offer temporary relief in the form of the Power Breezer and O2. Breezer Mobile Cooling is a Florida based company, but our products are available to individuals, organizations, and companies around the globe. Our Research and Development Department has concentrated on the intensive needs of individuals working and living in the hottest climates and situations and developed products to help manage high temperatures and reduce heat-related injuries. The design of our products is meant to accommodate the conditions in the harshest environments. The compact, strong, and easy to assemble Power Breezer addresses heat issues by quietly cooling over 3,000 sq. ft. by up to 27°F, and the O2 uses similar technology in a more compact package.

To find out more, contact our International Department at 001-954-418-4530 or by visiting https://powerbreezer.com/contact/.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512